Japan has made regenerative medicine a priority. It was the first country to approve clinical use of iPS cells, and it ...

Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...

Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease.

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it. After treatment with CAR-T ...

Study in mice found transient microglial depletion, or chemokine receptor blockade, resolved immunotherapy-related cognitive impairment.

First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research ...

A cell’s primary cilia function like antennae. Operating like a 24/7 news outlet, these hairlike structures are present on ...

A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Stem cell injections, platelet rich plasma and ivermectin do big business despite dubious or no evidence supporting their use in rheumatology. However, far from being a recent development, this type ...

Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively ...

A new gene editor takes advantage of CRISPR-associated proteins to insert whole genes into the genome, scientists report.

Several ASX-listed companies have partnered with Cell Therapies, based at Peter Mac to manufacture CAR-T and other cell ...